PCSK6 ablation increases atherosclerotic burden, but provides plaque stability by regulating TH17 and smooth muscle cell content
Autor: | Matic, L., Suur, B., Karadimou, G., Willems, C., Bergman, O., Lengquist, M., Kronqvist, M., Baumgartner, R., Malin, S., Gisterå, A., Hansson, G., Mälarstig, A., Hedin, U., Ketelhuth, D. |
---|---|
Zdroj: | In Atherosclerosis August 2023 379 Supplement 1:S23-S23 |
Databáze: | ScienceDirect |
Externí odkaz: |